Eli Casdin didn’t have to look very far to find a merger partner for the special purpose acquisition company that his firm, Casdin Capital, co-sponsored with Keith Meister’s Corvex Management earlier this year.The blank-check company, CM Life Sciences III, on Friday announced that it is combining with EQRx, which describes